159 related articles for article (PubMed ID: 28255377)
1. Pathophysiological changes of inflammatory syndrome in multiple sclerosis after instituting therapeutic plasmapheresis.
Vlaic S; Poalelungi V; Bălăeţ M; Purcărea VL; Bălăeţ C; Coculescu BI
J Med Life; 2017; 10(1):50-53. PubMed ID: 28255377
[TBL] [Abstract][Full Text] [Related]
2. Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis.
Stefoski D; Schauf CL; McLeod BC; Haywood CP; Davis FA
Neurology; 1982 Aug; 32(8):904-7. PubMed ID: 7201588
[TBL] [Abstract][Full Text] [Related]
3. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
4. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
[TBL] [Abstract][Full Text] [Related]
5. A closer look at plasmapheresis in multiple sclerosis: the cons.
Tindall R
Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
[TBL] [Abstract][Full Text] [Related]
6. [Plasmapheresis in neurology -- personal experience].
Załeska B; Domzał T; Korsak J
Neurol Neurochir Pol; 1994; 28(2):167-74. PubMed ID: 8047226
[TBL] [Abstract][Full Text] [Related]
7. Assessment of therapeutic plasmapheresis in demyelinating neurologic disorders.
Tindall RS; Rollins JA
South Med J; 1986 Aug; 79(8):991-7. PubMed ID: 3016910
[TBL] [Abstract][Full Text] [Related]
8. Removal of valproic acid by plasmapheresis in a patient treated for multiple sclerosis.
Bastiaans DE; van Uden IW; Ruiterkamp RA; de Jong BA
Ther Drug Monit; 2013 Feb; 35(1):1-3. PubMed ID: 23222689
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
[TBL] [Abstract][Full Text] [Related]
10. Plasmapheresis in multiple sclerosis: preliminary study.
Weiner HL; Dawson DM
Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
[TBL] [Abstract][Full Text] [Related]
11. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP
Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928
[TBL] [Abstract][Full Text] [Related]
12. Experience with use of plasmapheresis in chronic progressive multiple sclerosis: the pros.
Khatri BO
Neurology; 1988 Jul; 38(7 Suppl 2):50-2. PubMed ID: 3290715
[TBL] [Abstract][Full Text] [Related]
13. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
[TBL] [Abstract][Full Text] [Related]
14. Interferon inhibitor factor predicting success of plasmapheresis in patients with multiple sclerosis.
Medenica RD; Mukerjee S; Huschart T; Corbitt W
J Clin Apher; 1994; 9(4):216-21. PubMed ID: 7759466
[TBL] [Abstract][Full Text] [Related]
15. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
16. Plasmapheresis combined with interferon: an effective therapy for multiple sclerosis.
Medenica RD; Mukerjee S; Alonso K; Lazovic G; Huschart T
J Clin Apher; 1994; 9(4):222-7. PubMed ID: 7538999
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic apheresis in multiple sclerosis].
Nomura K
Nihon Rinsho; 2003 Aug; 61(8):1388-95. PubMed ID: 12962028
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with additional plasmapheresis for the exacerbation of acute neurological symptoms in a girl with multiple sclerosis].
Mogami Y; Yamada K; Toribe Y; Yanagihara K; Mano T; Suzuki Y
No To Hattatsu; 2011 Jan; 43(1):36-40. PubMed ID: 21400930
[TBL] [Abstract][Full Text] [Related]
19. Childhood multiple sclerosis treated with plasmapheresis.
Takahashi I; Sawaishi Y; Takeda O; Enoki M; Takada G
Pediatr Neurol; 1997 Jul; 17(1):83-7. PubMed ID: 9308985
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis in acute multiple sclerosis: rationale and results.
Dau PC
J Clin Apher; 1991; 6(4):200-4. PubMed ID: 1816240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
